Introduction: Mesenchymal stem cells (MSCs) were proposed as a critical therapeutic candidate in diabetic nephropathy (DN). Renal stem cells as a source for repairing are controversial. The purpose of the present study was to evaluate the effect of kidney rat stem cells on DN. Materials and methods: After separation of renal stem cells from rat kidney, the surface Stem cell markers were assessed by flow cytometry analysis. To establish the diabetic nephropathy rat model STZ(60mg/kg) was used. The cells were injected to experimental groups via tail vein (2×106cells/rat). Biochemical and histological parameters were evaluated in order to determining the impact of stem cells on kidney structure. Phosphorylation of Smad2/3 two weeks after induc...
Copyright © 2015 Fernando Ezquer et al. This is an open access article distributed under the Creativ...
Chronic kidney disease (CKD) is a major health care problem, affecting more than 35% of the elderly ...
Twenty-five to 40% of diabetic patients develop diabetic nephropathy, a clinical syndrome that compr...
AbstractMesenchymal stem cells (MSC) attenuate albuminuria and preserve normal renal histology in di...
Both types of diabetes mellitus (DM) are recognized by the destruction of pancreas or deficient func...
Mesenchymal stem cells (MSCs) are shown to alleviate renal injury of diabetic nephropathy (DN) in ra...
Mesenchymal stem cells (MSCs) possess pleiotropic properties that include immunomodulation, inhibiti...
The aim of our work was to evaluate, in an animal model of severe diabetes mellitus, the effect of m...
Introduction: Diabetic nephropathy (DN), a chronic kidney disease, is a major cause of end-stage kid...
The use of mesenchymal stromal cells (MSC) in diabetic models as a possible therapy to ameliorate di...
Objective: To investigate the role of mesenchymal stem cells in fibrogenesis using a model of chroni...
The potential protective effects of mesenchymal stem cells (MSCs) on some kidney diseases have been ...
Background/Aims: Diabetic nephropathy is one of the main causes of end-stage renal disease. The pres...
Regeneration of damaged kidney cells using stem cells is the current research approach in the treatm...
Diabetic nephropathy (DN) is a devastating complication associated with diabetes mellitus, and it is...
Copyright © 2015 Fernando Ezquer et al. This is an open access article distributed under the Creativ...
Chronic kidney disease (CKD) is a major health care problem, affecting more than 35% of the elderly ...
Twenty-five to 40% of diabetic patients develop diabetic nephropathy, a clinical syndrome that compr...
AbstractMesenchymal stem cells (MSC) attenuate albuminuria and preserve normal renal histology in di...
Both types of diabetes mellitus (DM) are recognized by the destruction of pancreas or deficient func...
Mesenchymal stem cells (MSCs) are shown to alleviate renal injury of diabetic nephropathy (DN) in ra...
Mesenchymal stem cells (MSCs) possess pleiotropic properties that include immunomodulation, inhibiti...
The aim of our work was to evaluate, in an animal model of severe diabetes mellitus, the effect of m...
Introduction: Diabetic nephropathy (DN), a chronic kidney disease, is a major cause of end-stage kid...
The use of mesenchymal stromal cells (MSC) in diabetic models as a possible therapy to ameliorate di...
Objective: To investigate the role of mesenchymal stem cells in fibrogenesis using a model of chroni...
The potential protective effects of mesenchymal stem cells (MSCs) on some kidney diseases have been ...
Background/Aims: Diabetic nephropathy is one of the main causes of end-stage renal disease. The pres...
Regeneration of damaged kidney cells using stem cells is the current research approach in the treatm...
Diabetic nephropathy (DN) is a devastating complication associated with diabetes mellitus, and it is...
Copyright © 2015 Fernando Ezquer et al. This is an open access article distributed under the Creativ...
Chronic kidney disease (CKD) is a major health care problem, affecting more than 35% of the elderly ...
Twenty-five to 40% of diabetic patients develop diabetic nephropathy, a clinical syndrome that compr...